These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20424400)

  • 1. Treatment of hypertension in athletes: an evidence-based review.
    Asplund C
    Phys Sportsmed; 2010 Apr; 38(1):37-44. PubMed ID: 20424400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension update and cardiovascular risk reduction in physically active individuals and athletes.
    Oliveira LP; Lawless CE
    Phys Sportsmed; 2010 Apr; 38(1):11-20. PubMed ID: 20424397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategy in arterial hypertension].
    Waeber B; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Feb; 117(7):227-38. PubMed ID: 2882599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for evidence in hypertension management: historical perspective.
    Moawad MA
    Ann Saudi Med; 2005; 25(5):367-74. PubMed ID: 16270757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing hypertension in athletes and physically active patients.
    Niedfeldt MW
    Am Fam Physician; 2002 Aug; 66(3):445-52. PubMed ID: 12182522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of hypertension in patients with diabetes.
    Whalen KL; Stewart RD
    Am Fam Physician; 2008 Dec; 78(11):1277-82. PubMed ID: 19069021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
    Zanchetti A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
    Caro JJ; Speckman JL; Salas M; Raggio G; Jackson JD
    CMAJ; 1999 Jan; 160(1):41-6. PubMed ID: 9934342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
    Ishimitsu T
    Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of arterial hypertension. Reflections and suggestions].
    Franchi F; Fabbri G
    Clin Ter; 1989 May; 129(4):299-313. PubMed ID: 2527124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.